These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16998)

  • 1. Unusual alpha adrenergic receptor potency of methyldopa metabolites on melanocyte function.
    Pettinger WA
    J Pharmacol Exp Ther; 1977 Jun; 201(3):622-6. PubMed ID: 16998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain.
    Louis WJ; Conway E; Summers R; Beart P; Jarrott B
    Hypertension; 1984; 6(5 Pt 2):II40-4. PubMed ID: 6094348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive metabolites of alpha-methyldopa.
    Robertson D; Tung CS; Goldberg MR; Hollister AS; Gerkens JF; Oates JA
    Hypertension; 1984; 6(5 Pt 2):II45-50. PubMed ID: 6094349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-methyldopa reduces locomotor activity in rats via its metabolite, alpha-methylnorepinephrine, acting on alpha 2-adrenoceptors.
    Clineschmidt BV; Flataker LM; Faison EP; Haubrich DR
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):231-43. PubMed ID: 6250499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of alpha-methyldopa, alpha-methylnorepinephrine, and octopamine on rat arteriolar, arterial, and terminal vascular smooth.
    Altura BM
    Circ Res; 1975 Jun; 36(6 Suppl 1):233-40. PubMed ID: 1093755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
    Goldberg MR; Tung CS; Feldman RD; Smith HE; Oates JA; Robertson D
    J Pharmacol Exp Ther; 1982 Mar; 220(3):552-60. PubMed ID: 7062266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and alpha adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors.
    Dubocovich ML; Langer SZ
    J Pharmacol Exp Ther; 1980 Jan; 212(1):144-52. PubMed ID: 6101339
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the hypotensive action of alpha-methyldopamine.
    Finch L; Hersom A; Hicks P
    Br J Pharmacol; 1975 Aug; 54(4):445-51. PubMed ID: 1100157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in brain alpha-adrenergic receptors after alpha-methyldopa administration to spontaneously hypertensive rats.
    Freed CR; Wang CH; U'Prichard DC
    Hypertension; 1984; 6(5 Pt 2):II34-9. PubMed ID: 6094347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha-methylnoradrenaline and alpha-methyldopamine in reserpine-induced ulcers in rats.
    Sandor V; Cuparencu B
    Pharmacology; 1981; 23(2):91-4. PubMed ID: 7031706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereostructure activity relationships of catecholamines on human platelet function.
    Ahn CH; Shams G; Schotzinger RL; Miller DD; Feller DR
    Proc Soc Exp Biol Med; 1990 Jun; 194(2):149-56. PubMed ID: 2190233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of carbidopa to alpha-methyldopamine and alpha-methylnorepinephrine in rats.
    Shelton RC; Karoum F; Chuang LW; Wyatt RJ
    Biochem Pharmacol; 1985 Oct; 34(20):3623-6. PubMed ID: 3902027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies.
    Wiggins JF; Sved AF; Fernstrom JD
    J Pharmacol Exp Ther; 1980 Feb; 212(2):304-8. PubMed ID: 6766188
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereochemical requirements of alpha-2 adrenergic receptors.
    Ruffolo RR; Yaden EL; Waddell JE
    J Pharmacol Exp Ther; 1982 Sep; 222(3):645-51. PubMed ID: 6286929
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulfhydryl requirement for alpha adrenergic receptor activity and melanophore stimulating hormone (MSH) action on melanophores.
    Goldman JM; Hadley ME
    J Pharmacol Exp Ther; 1972 Jul; 182(1):93-100. PubMed ID: 4402853
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of adrenergic agents with alpha-melanocyte-stimulating hormone and infrared irradiation of the iris in the rabbit eye.
    Bengtsson E
    Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):209-17. PubMed ID: 191423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of epinephrine, norepinephrine, dopamine and their corresponding alpha-methyl-substituted derivatives with alpha and beta adrenoceptors in the pithed rat.
    Ruffolo RR; Goldberg MR; Morgan EL
    J Pharmacol Exp Ther; 1984 Sep; 230(3):595-600. PubMed ID: 6381693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholaminergic activation of G-protein coupling in rat spinal cord: further evidence for the existence of dopamine and noradrenaline receptors in spinal grey and white matter.
    Venugopalan VV; Ghali Z; Sénécal J; Reader TA; Descarries L
    Brain Res; 2006 Jan; 1070(1):90-100. PubMed ID: 16423330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells.
    Nakaki T; Nakayama M; Yamamoto S; Kato R
    Mol Pharmacol; 1990 Jan; 37(1):30-6. PubMed ID: 2153907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins.
    Curro FA; Greenberg S; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1978 Dec; 207(3):936-49. PubMed ID: 215746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.